Surgery Partners (SGRY) director adds 10,000 shares in open-market buy
Rhea-AI Filing Summary
Surgery Partners, Inc. (SGRY) director Teresa DeLuca reported an open-market purchase of company stock. On 2026-08-18 she purchased 10,000 shares of common stock at a weighted average price of $14.35 per share, and now directly holds 66,843 shares of Surgery Partners common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 10,000 shares
Net Buy
1 txn
Insider
DeLuca Teresa
Role
Director
Bought
10,000 shs ($144K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1 | 10,000 | $14.35 | $144K |
Holdings After Transaction:
Common Stock — 66,843 shares (Direct)
Footnotes (1)
- F1. The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
Key Figures
Shares purchased: 10,000 shares
Weighted average purchase price: $14.35 per share
Shares owned after transaction: 66,843 shares
3 metrics
Shares purchased
10,000 shares
Common Stock acquired on 2026-08-18 in open-market or private transaction
Weighted average purchase price
$14.35 per share
Price for the 10,000-share Common Stock purchase on 2026-08-18
Shares owned after transaction
66,843 shares
Total direct holdings of Common Stock following the reported purchase
Key Terms
Form 4, weighted average price, open market or private transaction
3 terms
Form 4 regulatory
"reported an open-market purchase of company stock on Form 4"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open market or private transaction financial
"transaction code description: Purchase in open market or private transaction"
FAQ
What insider transaction did SGRY director Teresa DeLuca report?
Director Teresa DeLuca reported purchasing 10,000 shares of Surgery Partners common stock on 2026-08-18. The transaction was coded as a "P" open-market or private purchase on Form 4.
At what price did Teresa DeLuca buy SGRY stock in this Form 4?
She purchased the shares at a weighted average price of $14.35 per share. A footnote states she can provide full details of the number of shares bought at each separate price upon request.
Was Teresa DeLuca’s SGRY trade under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and no footnote describes a trading plan. The transaction is therefore not identified as made under a Rule 10b5-1 plan in this report.
What type of security did Teresa DeLuca acquire in SGRY?
She acquired Common Stock of Surgery Partners, Inc. The Form 4 reports a non-derivative transaction, meaning it involved direct share purchases rather than options or other derivative securities.
AI-generated analysis. How Rhea-AI works. Not financial advice.
